Igama elijwayelekile: | I-Tirzepatide |
Inombolo yeCas: | 2023788-19-2 |
I-Molecular Formula: | I-C225H348N48O68 |
Isisindo samangqamuzana: | 4813.45 g/mol |
Ukulandelana: | H-Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu -(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
Ukubukeka: | Impushana emhlophe |
Isicelo: | I-Tirzepatide iyisidakamizwa esicwaningwayo ukuze sisetshenziswe ekwelapheni isifo sikashukela sohlobo 2.Kungokwesigaba sezidakamizwa ezibizwa nge-diglucose-dependent insulinotropic peptide (GIP) kanye ne-glucagon-like peptide-1 (GLP-1) receptor agonists.I-Tezepatide isebenza ngokuvuselela ama-GIP nama-GLP-1 receptors emzimbeni.Lawa ma-receptors adlala indima ebalulekile ekulawuleni amazinga kashukela egazini kanye ne-metabolism.Ngokuvula la ma-receptors, i-tezepatide inyusa ukukhiqizwa kwe-insulin futhi yehlisa ukukhiqizwa kwe-glucagon, i-hormone enyusa amazinga kashukela egazini.Iphinde ibambezele ukuphuma kwesisu futhi isize ukulawula amazinga kashukela egazini.Ukuhlolwa kwemitholampilo kubonise ukuthi i-tilsiparatide ingalawula ngempumelelo amazinga kashukela egazini ezigulini ezinesifo sikashukela sohlobo 2.Kutholakale futhi ukukhuthaza ukulahlekelwa isisindo, okuyinzuzo eyengeziwe kubantu abaningi abanesifo sikashukela sohlobo lwe-2 abanobunzima bokugcina isisindo esinempilo.Enye yezinzuzo ze-tezeparatide uhlobo lwayo lokudosa olukanye ngeviki, olungase lwandise ukunethezeka nokuhambisana nohlelo lokwelapha.Lokhu kungase kube usizo ikakhulukazi kubantu abanobunzima bokunamathela kushejuli yemithi yansuku zonke noma abakhetha uhlelo lokwelapha olulula.Kufanele kuqashelwe ukuthi i-tilsparatide isesigabeni sokuphenya futhi ayikagunyazwa ukuthi isetshenziswe yizikhungo ezilawulayo.Ucwaningo olwengeziwe luyadingeka ukuze kutholwe ukuphepha nokusebenza kwayo kwesikhathi eside kanye nokuhlonza noma yimiphi imiphumela emibi engaba khona.Kafushane, i-tilsiparatide umuthi omusha ophenywayo wokwelapha uhlobo 2 sikashukela.Isenzo sayo esimbaxambili ku-GIP kanye ne-GLP-1 receptors sinamandla okuthuthukisa ukulawulwa kwe-glycemic nokuncipha kwesisindo.Kodwa-ke, ucwaningo olwengeziwe luyadingeka ngaphambi kokuthi i-tilsiparatide inconywe njengendlela yokwelapha yabantu abanesifo sikashukela sohlobo 2. |
Iphakheji: | isikhwama se-aluminium foil noma i-aluminium TIN noma ngokwezidingo zekhasimende ngalinye |
1 | Umhlinzeki oqeqeshiwe wama-API we-peptide ovela e-China. |
2 | Imigqa yokukhiqiza engu-16 enamandla okukhiqiza amakhulu anenani elincintisanayo |
3 | I-DMF itholakala nemibhalo ethembeke kakhulu. |
A: Yebo, singapakisha njengemfuneko yakho.
A: I-LC sight kanye ne-TT esikhathini sokukhokha kusengaphambili esikhethwayo.
IMP: Yebo, sicela unikeze ukucaciswa kwekhwalithi yakho, sizohlola i-R&D yethu futhi sizame ukufanisa ukucaciswa kwekhwalithi yakho.